Amantadine in parkinson’s disease: modern possibilities of long-term therapy
The long-term therapy of Parkinson’s disease (PD) with dopaminergic drugs is naturally accompanied by the fluctuations in symptoms and dyskinesia, and these complications are an extremely important factor that adversely affects the quality of life. The hyperactivity of glutamate NMDA receptors of th...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Russo |
| Julkaistu: |
Remedium Group LLC
2018-05-01
|
| Sarja: | Медицинский совет |
| Aiheet: | |
| Linkit: | https://www.med-sovet.pro/jour/article/view/2473 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|